Pulmonx (LUNG) Operating Leases (2019 - 2025)

Pulmonx (LUNG) has reported Operating Leases for 7 consecutive years, with $18.1 million the latest figure, recorded in Q4 2025.

• On a quarterly basis, Operating Leases fell 2.46% year-over-year to $18.1 million in Q4 2025; TTM through Dec 2025 was $18.1 million, a 2.46% decrease from a year earlier, with the FY2025 full-year figure at $18.1 million, down 2.46% from the prior year.
• Operating Leases was $18.1 million for Q4 2025 at Pulmonx, down from $19.4 million in the prior quarter.
• Over five years, Operating Leases peaked at $19.8 million in Q1 2025 and troughed at $1.1 million in Q4 2023.
• A 5-year average of $10.9 million and a median of $9.0 million in 2021 frame the typical range for Operating Leases.
• Across the five-year window, Operating Leases slumped 71.27% in 2023 and jumped 1574.05% in 2024, its largest moves.
• Over 5 years, Operating Leases stood at $6.8 million in 2021, then slumped by 43.76% to $3.8 million in 2022, then tumbled by 71.27% to $1.1 million in 2023, then jumped by 1574.05% to $18.5 million in 2024, then dropped by 2.46% to $18.1 million in 2025.
• The last three Operating Leases figures came in at $18.1 million (Q4 2025), $19.4 million (Q3 2025), and $19.7 million (Q2 2025), per Business Quant data.